Literature DB >> 10205773

Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination.

C H Chou1, L Aarons, M Rowland.   

Abstract

The axial dispersion model of hepatic drug elimination is characterized by two dimensionless parameters, the dispersion number, DN, and the efficiency number, RN, corresponding to the relative dispersion of material on transit through the organ and the relative efficiency of elimination of drug by the organ, respectively. Optimal design theory was applied to the estimation of these two parameters based on changes in availability (F) of drug at steady state for the closed boundary condition model, with particular attention to variations in the fraction of drug unbound in the perfusate (fuB). Sensitivity analysis indicates that precision in parameter estimation is greatest when F is low and that correlation between RN and DN is high, which is desirable for parameter estimation, when DN lies between 0.1 and 100. Optimal design points were obtained using D-optimization, taking into account the error variance model. If the error variance model is unknown, it is shown that choosing Poisson error model is reasonable. Furthermore, although not optimal, geometric spacing of fuB values is often reasonable and definitively superior to a uniform spacing strategy. In practice, the range of fuB available for selection may be limited by such practical considerations as assay sensitivity and acceptable concentration range of binding protein. Notwithstanding, optimal design theory provides a rational approach to precise parameter estimation.

Mesh:

Year:  1998        PMID: 10205773     DOI: 10.1023/a:1023229318017

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  25 in total

1.  Design and analysis of protein binding experiments.

Authors:  A Z Khan; L Aarons
Journal:  J Theor Biol       Date:  1989-09-22       Impact factor: 2.691

2.  Lack of linear correlation between hepatic ligand uptake rate and unbound ligand concentration does not necessarily imply receptor-mediated uptake.

Authors:  R H Smallwood; D J Morgan; G W Mihaly; R A Smallwood
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

3.  Multiple-objective criteria for optimal experimental design: application to ferrokinetics.

Authors:  M H Nathanson; G M Saidel
Journal:  Am J Physiol       Date:  1985-03

4.  Physiologic models of hepatic drug clearance: influence of altered protein binding on the elimination of diclofenac in the isolated perfused rat liver.

Authors:  Z Hussein; A M Evans; M Rowland
Journal:  J Pharm Sci       Date:  1993-09       Impact factor: 3.534

5.  Flow dependence of propranolol elimination in perfused rat liver.

Authors:  S Keiding; E Steiness
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

6.  Design and optimization of tracer experiments in physiology and medicine.

Authors:  J J DiStefano
Journal:  Fed Proc       Date:  1980-01

7.  Optimal design of experiments for the estimation of precise hyperbolic kinetic and binding parameters.

Authors:  L Endrenyi; F Y Chan
Journal:  J Theor Biol       Date:  1981-05-21       Impact factor: 2.691

8.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

9.  Design of experiments for the precise estimation of dose-response parameters: the Hill equation.

Authors:  M Bezeau; L Endrenyi
Journal:  J Theor Biol       Date:  1986-12-21       Impact factor: 2.691

10.  Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.

Authors:  M S Ching; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

View more
  2 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.